In a research report issued today, Piper Jaffray analyst Gene Munster reiterated an Overweight rating on LinkedIn Corp (NYSE:LNKD) with a $297 price target, after …
Piper Jaffray analyst Gene Munster came out today with an optimistic view on Apple Inc.’s (NASDAQ:AAPL) Watch, following the company’s much-anticipated Spring event in San Francisco.
In a research report issued today, Piper Jaffray analyst Gene Munster reiterated a Buy rating on Apple Inc. (NASDAQ:AAPL) with a $160 price target, …
In a research report issued today, Piper Jaffray analyst Gene Munster (TipRanks’ #1) maintained an Overweight rating on Facebook Inc (NASDAQ:FB) with an $84 price target, …
In a research report issued today, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on Pharmacyclics, Inc. (NASDAQ:PCYC) with a price target of …
In a research report issued Monday, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) with a $68 price …
In a research report released this morning, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on Insmed Incorporated (NASDAQ:INSM) with a $51 price …
Piper Jaffray analyst Joshua Schimmer came out with a research note on Nektar Therapeutics (NASDAQ:NKTR), following the company’s fourth-quarter results posting revenue of $19.5 million compared to Jaffray’s estimate …
In a research report published Wednesday, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on MannKind Corporation (NASDAQ:MNKD) with a $7 price target, following …
Piper Jaffray’s healthcare analyst Joshua Schimmer weighed in today with a few insights on Pharmacyclics, Inc. (NASDAQ:PCYC), following the release of the company’s fourth-quarter results, posting GAAP net …
